Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought

Links shared publicly online about this topic.

  • 2,059
    total visits

Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought

medicalnewstoday.com

The risk of developing progressive multifocal leukoencephalopathy (PML), a viral brain infection, in patients with multiple sclerosis (MS) taking the drug natalizumab (Tysabri) appears to be much

View full resource at medicalnewstoday.com

Tags: Infection, Brain, Encephalitis, Multiple Sclerosis, Drug, Tysabri

  • Share

Most Recently Shared on May 8, 2009 at 2:37 pm By:

LisaEmrich Lisa Emrich

MedNewsToday: Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought: Th.. http://tinyurl.com/re7kp3

3 years ago...

Advertisement